ArticleDrug and alcohol dependence2021
Prevalence and minority-stress correlates of past 12-month prescription drug misuse in a national sample of transgender and gender nonbinary adults: Results from the U.S. Transgender Survey.
Article in Drug and alcohol dependence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 48 citations in OpenAlex.
- The Greatest Challenges after Gender-Affirming Vaginoplasty: A Qualitative Analysis.Transgender health · 2026Article
- Substance Use Patterns Across the Sexual Identity Spectrum Among U.S. Individuals.The American journal of psychiatry · 2026Article
- Forms of transphobia and their influence on health outcomes among transgender, nonbinary, and gender diverse individuals: a global systematic review.International journal of transgender health · 2025Article
- Postoperative Opioid Prescription Size and Patient-reported Consumption Following Gender-affirming Mastectomy: A Prospective Survey Study.Plastic and reconstructive surgery. Global open · 2025Article
- Substance Use Prevalence Among Transgender and Gender Diverse Young Adults Across Identity and Life Experiences.Annals of LGBTQ public and population health · 2025Article
- Healthcare Mistreatment is Associated With Psychological Distress, Suicidality, and Substance Use Among Transgender and Nonbinary Emerging Adults.Emerging adulthood (Print) · 2025Article
- Transgender and Gender-Diverse Minority Stress and Substance Use Frequency and Problems: Systematic Review and Meta-Analysis.Transgender health · 2025Review
- Enhanced Recovery Protocol Decreases Postoperative Opioid Use after Penile Inversion Vaginoplasty.Plastic and reconstructive surgery. Global open · 2024Article
- Problems in management of medication overuse headache in transgender and gender non-conforming populations.Frontiers in neurology · 2024Review
- "I Think Providers See Trans People as Unstable Patients": Exploring Substance Use Communication Experiences of Transgender and Gender Diverse Adults During Primary Care Encounters.Psychology of sexual orientation and gender diversity · 2023Article
- Substance use patterns among a global sample of transgender and non-binary people during the COVID-19 pandemic.BMC global and public health · 2023Article
- Prevalence of substance use and mental health problems among transgender and cisgender U.S. adults: Results from a national probability sample.Psychiatry research · 2023Article
- Transgender/nonbinary young adults' exposure to cissexism-related social stressors: Variation across gender groups.Social science & medicine (1982) · 2023Article
- Examining the role of problematic drug use in the relationship between discrimination and sleep disturbance in transgender and nonbinary individuals.Addictive behaviors · 2022Article
- Substance Use in the Transgender Population: A Meta-Analysis.Brain sciences · 2022Review
- Opioid pain medication misuse, concomitant substance misuse, and the unmet behavioral health treatment needs of transgender and gender diverse adults.Drug and alcohol dependence · 2021Article
- Article
- Psychopharmacological Considerations for Gender-Affirming Hormone Therapy.Harvard review of psychiatryReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
backgroundPrescription drug (PD) misuse, particularly opioid misuse, is a major US public health concern. While transgender and gender nonbinary (TGNB) individuals experience numerous health disparities, including substance use disparities, little research has focused on PD misuse in this population.
methodsData for this secondary analysis come from the US Transgender Survey (N = 26,689). First, we examined bivariate differences in past 12-month PD misuse among binary transgender women, binary transgender men, nonbinary individuals assigned-female-at-birth (AFAB), and nonbinary individuals assigned-male-at-birth (AMAB). We then used multivariable logistic regression (separately based on sex-assigned-at-birth) to examine the relationship between gender-identity related discrimination and PD misuse.
resultsPD misuse was significantly more common among binary transgender men (17.3 %), nonbinary AFAB individuals (18.7 %), and nonbinary AMAB individuals (18.0 %); compared to binary transgender women (13.5 %). In multivariable analyses, nonbinary identity was associated with higher odds of PD misuse among TGNB AFAB individuals (OR = 1.121; 95 %CI 1.021-1.232) and AMAB individuals (OR = 1.315; 95 % CI 1.133-1.527). Controlling for overall health status and psychological distress, public accommodations discrimination was associated with PD misuse among TGNB AMAB individuals (OR = 1.578, 95 %CI 1.354-1.839). Among both groups, healthcare discrimination was associated with PD misuse (AFAB OR = 1.388, 95 %CI 1.255-1.534; AMAB OR = 1.227, 95 %CI 1.073-1.404).
conclusionIn this national sample of TGNB individuals, nonbinary individuals were at greater risk for PD misuse than binary individuals, possibly due to less societal affirmation. Similar to other TGNB health disparities, discrimination based on gender identity/expression was associated with PD misuse. This highlights the importance of interventions to reduce discrimination against TGNB individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.